ATE419361T1 - Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus - Google Patents

Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus

Info

Publication number
ATE419361T1
ATE419361T1 AT97920721T AT97920721T ATE419361T1 AT E419361 T1 ATE419361 T1 AT E419361T1 AT 97920721 T AT97920721 T AT 97920721T AT 97920721 T AT97920721 T AT 97920721T AT E419361 T1 ATE419361 T1 AT E419361T1
Authority
AT
Austria
Prior art keywords
antigen
monoclonal antibodies
hcv
molecules
hepatitis
Prior art date
Application number
AT97920721T
Other languages
English (en)
Inventor
Mats Axel Atterdag Persson
Tobias Erik Allander
Original Assignee
Molecules Of Man Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/635,109 external-priority patent/US6538114B1/en
Application filed by Molecules Of Man Ab filed Critical Molecules Of Man Ab
Application granted granted Critical
Publication of ATE419361T1 publication Critical patent/ATE419361T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/116—Togaviridae (F); Matonaviridae (F); Flaviviridae (F)
    • C07K16/118—Hepatitis C virus; GB virus C [GBV-C]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97920721T 1996-04-19 1997-04-18 Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus ATE419361T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/635,109 US6538114B1 (en) 1996-04-19 1996-04-19 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
US08/844,215 US6747136B2 (en) 1996-04-19 1997-04-17 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen

Publications (1)

Publication Number Publication Date
ATE419361T1 true ATE419361T1 (de) 2009-01-15

Family

ID=27092301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97920721T ATE419361T1 (de) 1996-04-19 1997-04-18 Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus

Country Status (8)

Country Link
US (1) US6747136B2 (de)
EP (1) EP0937153B1 (de)
AT (1) ATE419361T1 (de)
CA (1) CA2262423C (de)
DE (1) DE69739187D1 (de)
DK (1) DK0937153T3 (de)
ES (1) ES2320051T3 (de)
WO (1) WO1997040176A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1097172A1 (de) * 1998-07-21 2001-05-09 Genmab A/S Anti-hepatitis c virus antikörper und verwendung davon
US7091324B2 (en) * 1998-11-05 2006-08-15 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
EP1127170A4 (de) * 1998-11-05 2005-04-27 Univ Leland Stanford Junior Menschliche monoklonale antikörper gegen menschlichen pan-hepatitis c virus
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
CA2380777C (en) * 1999-07-28 2011-01-04 Chiron Corporation Hepatitis c viral antigen immunoassay detection systems
IL137522A (en) 2000-07-26 2007-06-17 Drk Blutspendediendst Baden Wu Human monoclonal antibody against hepatitis c virus e2 glycoprotein
CA2429946A1 (en) 2000-12-01 2002-07-18 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
PT1360288E (pt) 2000-12-18 2011-03-07 Dyax Corp Bibliotecas orientadas de pacotes genéticos
ATE425187T1 (de) * 2001-01-12 2009-03-15 Molecules Of Man Ab Materialien und methoden zur behandlung von hepatitis c
WO2002059340A1 (en) * 2001-01-26 2002-08-01 The Scripps Research Institute Immunopolypeptides to hepatitis c virus
US20070178065A1 (en) * 2002-05-03 2007-08-02 Lattime Edmund C Neutralizing factors as vaccine adjuvants
WO2004027028A2 (en) * 2002-09-18 2004-04-01 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
US8551484B2 (en) 2007-02-21 2013-10-08 University Of Massachusetts Human antibodies against hepatitis C virus (HCV) and uses thereof
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
US20130129676A1 (en) 2010-05-25 2013-05-23 Universite De Strasbourg Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
CN115028711B (zh) * 2021-05-08 2024-02-09 南昌大学 一种高亲和力抗丙型肝炎病毒的全人源单克隆抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308750A (en) 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
EP0447984A1 (de) 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
FR2677372B1 (fr) * 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
EP0605522B1 (de) 1991-09-23 1999-06-23 Medical Research Council Methoden zur Herstellung humanisierter Antikörper

Also Published As

Publication number Publication date
DK0937153T3 (da) 2009-05-04
ES2320051T3 (es) 2009-05-18
CA2262423C (en) 2010-08-03
US20020016445A1 (en) 2002-02-07
WO1997040176A1 (en) 1997-10-30
DE69739187D1 (de) 2009-02-12
CA2262423A1 (en) 1997-10-30
EP0937153A1 (de) 1999-08-25
US6747136B2 (en) 2004-06-08
EP0937153B1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
DE69739187D1 (de) Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus
ATE425989T1 (de) Proteinreinigungsverfahren
Creighton The single-disulphide intermediates in the refolding of reduced pancreatic trypsin inhibitor
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE59109271D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
AU2001294541A1 (en) Mammalian genes; related reagents and methods
ATE362534T2 (de) Menschliche tslp nukleinsäuren und polypeptide
HUP9802401A2 (hu) Az emberi gp39-protein különböző epitópjaira specifikus monoklonális antitestek, valamint eljárások az ilyen antitestek diagnosztikai és terápiás alkalmazására
MXPA02011163A (es) Anticuerpos igm humanos con la capacidad de inducir remielinacion, y usos diagnosticos y terapeuticos de los mismos particularmente en el sistema nervioso central.
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ES2098274T3 (es) Anticuerpos monoclonales.
ATE370235T1 (de) Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
EA201001190A1 (ru) Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков
KR960705038A (ko) 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease)
ATE382696T1 (de) Immunoreaktive antigene des hepatitis e viruses
DK1181366T3 (da) Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
Michiyo et al. Functional properties of the allotypes of mouse complement regulatory protein, factor H: difference of compatibility of each allotype with human factor I
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
BR0204599A (pt) Sequências de proteìna de núcleo de hcv
Wasniowska et al. An immunoblotting procedure for screening glycophorins and band 3 protein in the same blots: Identification of glycophorin and band 3 variant forms

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties